Attenuation of postoperative acute liver failure by mesenchymal stem cell treatment due to metabolic implications

Annals of Surgery

Volumn 263, Issue 3, 2016, Pages 546-556

  Tautenhahn, Hans Michael ^a,b   Bruckner, Sandra ^a   Baumann, Sven ^b,c   Winkler, Sandra ^a   Otto, Wolfgang ^c   Bergen, Martin Von ^c,d   Bartels, Michael ^a   Christ, Bruno ^a,b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

Cell transplantation; liver regeneration; mesenchymal stem cells; metabolism; posthepatectomy liver failure

Indexed keywords

ACYLCARNITINE; ALANINE AMINOTRANSFERASE; AMINO ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; EOSIN; GLYCEROPHOSPHOLIPID; HEMATOXYLIN; OIL SCARLET; SPHINGOLIPID;

ACUTE LIVER FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FATTY LIVER; INTERNATIONAL NORMALIZED RATIO; LIPID STORAGE; LIVER CELL; LIVER FUNCTION; LIVER HISTOLOGY; LIVER INJURY; LIVER REGENERATION; LIVER RESECTION; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLOMICS; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; SURVIVAL; ADIPOSE TISSUE; ANIMAL; CYTOLOGY; ENZYME IMMUNOASSAY; FISCHER 344 RAT; LIVER FAILURE, ACUTE; LIVER FUNCTION TEST; METABOLISM; PHYSIOLOGY; STAINING; TUNEL ASSAY;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; HEPATECTOMY; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; LIVER REGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLOMICS; RATS; RATS, INBRED F344; STAINING AND LABELING;

EID: 84959258241     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001155     Document Type: Article

References (48)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Schutte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis. 2009;27:80-92.
3. Schindl MJ, Redhead DN, Fearon KC, et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54:289-296.
4. Guglielmi A, Ruzzenente A, Conci S, et al. How much remnant is enough in liver resection? Dig Surg. 2012;29:6-17.
5. Walldorf J, Hillebrand C, Aurich H, et al. Propranolol impairs liver regeneration after partial hepatectomy in C57Bl(6-mice by transient attenuation of hepatic lipid accumulation and increased apoptosis. Scand J Gastroenterol. 2010;45:468-476.
6. Farrell GC. Probing Prometheus: fat fueling the fire? Hepatology. 2004;40:1252-1255.
7. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology. 2004;39:1477-1487.
8. Shteyer E, Liao Y, Muglia LJ, et al. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology. 2004;40:1322-1332.
9. Newberry EP, Kennedy SM, Xie Y, et al. Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models. Hepatology. 2008;48:1097-1105.
10. Feldstein AE, Canbay A, Angulo P, et al. Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology. 2003;125:437-443.
11. Hamano M, Ezaki H, Kiso S, et al. Lipid overloading during liver regeneration causes delayed hepatocyte DNA replication by increasing ER stress in mice with simple hepatic steatosis. J Gastroenterol. 2014;49:305-316.
12. Ezzat TM, Dhar DK, Newsome PN, et al. Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet? Liver Int. 2011;31:773-784.
13. Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:321-334.
14. Gotherstrom C. Immunomodulation by multipotent mesenchymal stromal cells. Transplantation. 2007;84:S35-S37.
15. van Poll D, Parekkadan B, Cho CH, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008;47:1634-1643.
16. Winkler S, Borkham-Kamphorst E, Stock P, et al. Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunedeficient mouse model. Exp Cell Res. 2014;326:230-239.
17. Stock P, Bruckner S,Winkler S, et al. Human bone marrowmesenchymal stem cell-derived hepatocytes improve the mouse liver after acute acetaminophen intoxication by preventing progress of injury. Int J Mol Sci. 2014;15:7004-7028.
18. Sgodda M, Aurich H, Kleist S, et al. Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res. 2007;313:2875-2886.
19. Christ B, Bruckner S, Stock P. Hepatic transplantation of mesenchymal stem cells in rodent animal models. Methods Mol Biol. 2011;698:315-330.
20. Christ B, Pelz S. Implication of hepatic stem cells in functional liver repopulation. Cytometry A. 2013;83:90-102.
21. Stock P, Bruckner S, Ebensing S, et al. The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver. Nat Protoc. 2010;5:617-627.
22. Waynforth HB, Flecknell PA. Rats as laboratory animals. In: Experimental and Surgical Technique in the Rat. London: Academic Press; 1992: 255-257.
23. Römisch-Margl W, Prehn C, Bogumil R, et al. Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics. Metabolomics. 2012;8:133-142.
24. Delahunty TJ, Rubinstein D. Accumulation and release of triglycerides by rat liver following partial hepatectomy. J Lipid Res. 1970;11:536-543.
25. Tijburg LB, Nyathi CB, Meijer GW, et al. Biosynthesis and secretion of triacylglycerol in rat liver after partial hepatectomy. Biochem J. 1991;277: 723-728.
26. Stein TA, Burns GP, Tropp BE, et al. Hepatic fat accumulation during liver regeneration. J Surg Res. 1985;39:338-343.
27. Fernandez MA, Albor C, Ingelmo-Torres M, et al. Caveolin-1 is essential for liver regeneration. Science. 2006;313:1628-1632.
28. Lafontan M, Barbe P, Galitzky J, et al. Adrenergic regulation of adipocyte metabolism. Hum Reprod. 1997;12(suppl 1):6-20.
29. Knopp J, Jezova D, Rusnak M, et al. Changes in plasma catecholamine and corticosterone levels and gene expression of key enzymes of catecholamine biosynthesis in partially hepatectomized rats. Endocr Regul. 1999;33:145-153.
30. Nguyen P, Leray V, Diez M, et al. Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl). 2008;92:272-283.
31. Coleman RA, Lee DP. Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res. 2004;43:134-176.
32. Bechmann LP, Hannivoort RA, Gerken G, et al. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56:952-964.
33. Lai HS, Chen Y, Chen WJ. Carnitine contents in remnant liver, kidney, and skeletal muscle after partial hepatectomy in rats: randomized trial. World J Surg. 1998;22:42-46; discussion 46-47.
34. Houten SM, Wanders RJ. A general introduction to the biochemistry of mitochondrial fatty acid beta-oxidation. J InheritMetab Dis. 2010;33:469-477.
35. Bonnefont JP, Djouadi F, Prip-Buus C, et al. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med. 2004;25:495-520.
36. Rubio-Gozalbo ME, Bakker JA, Waterham HR, et al. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects. Mol Aspects Med. 2004;25:521-532.
37. Kaibori M, Kwon AH, Oda M, et al. Hepatocyte growth factor stimulates synthesis of lipids and secretion of lipoproteins in rat hepatocytes. Hepatology. 1998;27:1354-1361.
38. Jones LL, McDonald DA, Borum PR. Acylcarnitines: role in brain. Prog Lipid Res. 2010;49:61-75.
39. Hagen TM, Liu J, Lykkesfeldt J, et al. Feeding acetyl-l-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci USA. 2002;99:1870-1875.
40. Pillich RT, Scarsella G, Risuleo G. Reduction of apoptosis through the mitochondrial pathway by the administration of acetyl-l-carnitine to mouse fibroblasts in culture. Exp Cell Res. 2005;306:1-8.
41. Kathirvel E, Morgan K, French SW, et al. Acetyl-l-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. Nutr Res. 2013;33: 932-941.
42. Taniguchi M, Okazaki T. The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders. Biochim Biophys Acta. 2014;1841: 692-703.
43. Li Z, Fan Y, Liu J, et al. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2012;32:1577-1584.
44. Zhou L, Nilsson A. Sources of eicosanoid precursor fatty acid pools in tissues. J Lipid Res. 2001;42:1521-1542.
45. Kadowaki H, Patton GM, Robins SJ. Metabolism of high density lipoprotein lipids by the rat liver: evidence for participation of hepatic lipase in the uptake of cholesteryl ester. J Lipid Res. 1992;33:1689-1698.
46. Baisted DJ, Robinson BS, Vance DE. Albumin stimulates the release of lysophosphatidylcholine from cultured rat hepatocytes. Biochem J. 1988;253:693-701.
47. Holecek M, Mraz J, Koldova P, et al. Effect of polyunsaturated phosphatidylcholine on liver regeneration onset after hepatectomy in the rat. Arzneimittelforschung. 1992;42:337-339.
48. Holecek M, Skalska H, Mraz J. Plasma amino acid levels after carbon tetrachloride induced acute liver damage. A dose-response and time-response study in rats. Amino Acids. 1999;16:1-11.